GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

SL Science Holding Limited Ordinary Shares SLBT · USD

US listing · 🇺🇸 United States

Compare

0.98

+4.31%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$2.2m

FY2023FY2025

Net income

−$3.8m

FY2023FY2025

Free cash flow

−$2.2m

FY2023FY2025

Shareholders' equity

$2.3m

FY2023FY2025

Income statement

Fiscal years

FY2025FY2024FY2023
Revenue$2.2m$3.4m$878,971
Gross profit$775,062$1.9m$738,008
Research and development$2.1m$2.0m—
Operating income−$3.8m−$1.2m$96,828
Net income−$3.8m−$1.2m$399,035
Diluted earnings per share-0.01-0.000.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023
Total assets$2.8m$5.9m$4.2m
Cash and short-term investments$1.3m$3.7m$276,854
Total liabilities$533,277$204,899$668,066
Debt$148,663—$149,587
Shareholders' equity$2.3m$5.7m$3.6m
Shares outstanding561m561m561m

Cash flow

Fiscal years

FY2025FY2024FY2023
Cash from operations−$1.9m$280,158−$2.5m
Capital spending−$319,685−$7,970−$182,984
Free cash flow−$2.2m$272,188−$2.6m

Financial ratios

Data as of 2 Nov 2026

FY2025FY2024FY2023
Gross margin35.3%57.5%84.0%
Operating margin-174.6%-35.6%11.0%
Net margin-173.8%-35.4%45.4%
Return on equity-167.2%-20.8%11.2%
Return on assets-135.6%-20.1%9.4%
Free cash flow yield-0.2%0.0%—
Revenue growth-34.7%282.7%—
Earnings growth220.6%-398.6%—
Current ratio3.05x84.61x19.09x
Debt to equity0.07x—0.04x
Equity ratio81.1%96.5%84.3%
R&D as a share of sales94.2%60.1%—
Buybacks as a share of market value0.0%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin48.7%———

Valuation history

At each fiscal year end

FY2025
Price to earnings-467.8

Market value over time

28 Feb 2025 to 30 Oct 2026, in USD

$5.63bn$672.9m

Share price return

Finished calendar years

2025
Return5%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.